Yüklüyor......
Overview of FDA’s Expanded Access Program for Investigational Drugs
Expanded access, also called “compassionate use,” provides a pathway for patients to gain access to investigational drugs, biologics, and medical devices used to diagnose, monitor, or treat patients with serious diseases or conditions for which there are no comparable or satisfactory therapy options...
Kaydedildi:
| Yayımlandı: | Ther Innov Regul Sci |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2017
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5443564/ https://ncbi.nlm.nih.gov/pubmed/28553565 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2168479017694850 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|